Overview

Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)

Status:
Terminated
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetics of clarithromycin which is used for premature infants with ureaplasma.
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Clarithromycin